<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>26738231</identifier>
<setSpec>0210-5020</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Montserrat, Pallas Seijas</dc:author>
<dc:description xml:lang="en">Cryopreservation ofhuman oocytes to delay fertility also be an option for women who are going to be subjected to a cancer/autoimmune treatment. It allows for creating a bank of oocytes for donation in assisted reproduction centers. The legislation allows the use of cryopreserved oocytes throughout the reproductive life of women with what conservation could last up to 48-50 years. Oocyte vitrification is a ultrafast freezing method in which cryoprotectants are used to prevent the formation of ice crystals within the cell. Treatment for oocyte vitrification process is similar to IVF treatment, ending at the time of obtaining the ova. The eggs obtained in the laboratory are classified according to maturity and quality. The apartments will be cryopreserved by vitrification technique tanks and maintained in liquid nitrogen until used for reproductive purposes.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>2015 Sep </dc:date>
<dc:title xml:lang="es">Preservación de la fertilidad de la mujer: VITRIFICACIÓN DE OVOCITOS.</dc:title>
<dc:title xml:lang="en">[FERTILITY PRESERVATION OF WOMEN: OOCYTE VITRIFICATION].</dc:title>
<dc:publisher>Revista de enfermeria (Barcelona, Spain)</dc:publisher>
</metadata>
</record>
</pubmed-document>
